Sydney Brenner, John Sulston, and Robert Horvitz, the three pioneers in studying the model organism Caenorhabditis elegans, have been named as winners of the 2002 Nobel Prize for Physiology or Medicine. Brenner, a professor at the Salk Institute for Biological Sciences in San Diego; Sulston, of the Wellcome Trust Sanger Institute, and Horvitz, of MIT, will be formally awarded the $1 million prize at a December ceremony in Stockholm.
Shiv Tasker was named president and CEO of Worcester, Mass.-based Blackstone Computing. Tasker previously headed up clinical trials software vendor Phase Forward. Brian Ritchie, former CEO and president of Blackstone, is now serving as the company’s vice president of business development.
Tularik of South San Francisco has appointed Ira Stoler as vice president and CIO. Stoler, who will be developing strategies to integrate the company’s research and clinical development programs, comes to Tularik from Pfizer, where he was vice president of clinical and regulatory informatics.
Entelos of Menlo Park, Calif., has appointed Jon Saxe as chairman of the board. Saxe currently serves as and executive-in-residence at the venture capital firm Institutional Venture Partners. Saxe was previously president of Protein Design Labs, and president of biotech and pharmaceutical consulting firm Saxe Associates.
3rd Millennium has appointed Julie Klemm as senior project scientist. Klemm was the former director of scientific project management at Incyte Genomics.